bioRxivBiochemistry
Identification of Small Molecule Ligand Binding Sites On and In the ARNT PAS-B Domain
X. Xu, J. Closson, L. P. Marcelino, D. C. Favaro, M. L. Silvestrini, R. Solazzo, L. T. Chong, K. H. Gardner
Abstract
Transcription factors are generally challenging to target with small molecule inhibitors due to their structural plasticity and lack of catalytic sites. Notable exceptions include several naturally ligand-regulated transcription factors, including our prior work with the heterodimeric HIF-2 transcription factor which showed that small molecule binding within an internal pocket of the HIF-2 PAS-B domain can disrupt its interactions with its dimerization partner, ARNT. Here, we explore the feasibility of similarly targeting small molecules to the analogous ARNT PAS-B domain itself, potentially opening a promising route to simultaneously modulate several ARNT-mediated signaling pathways. Using solution NMR screening of an in-house fragment library, we previously identified several compounds that bind ARNT PAS-B and, in certain cases, antagonize ARNT association with the TACC3 transcriptional coactivator. However, these ligands have only modest binding affinities, complicating characterization of their binding sites. We address this challenge by combining NMR, MD simulations, and ensemble docking to identify ligand-binding hotspots on and within the ARNT PAS-B domain. Our data indicate that the two ARNT/TACC3 inhibitors, KG-548 and KG-655, bind to a {beta}-sheet surface implicated in both HIF-2 dimerization and coactivator recruitment. Furthermore, while KG-548 binds exclusively to the {beta}-sheet surface, KG-655 can additionally bind within a water-accessible internal cavity in ARNT PAS-B. Finally, KG-279, while not a coactivator inhibitor, exemplifies ligands that preferentially bind only to the internal cavity. All three ligands promoted ARNT PAS-B homodimerization, albeit to varying degrees. Taken together, our findings provide a comprehensive overview of ARNT PAS-B ligand-binding sites and may guide the development of more potent coactivator inhibitors for cellular and functional studies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prostaglandins as Candidate Ligands for a Per-ARNT-Sim (PAS) Domain of Steroid Receptor Coactivator 1 (SRC1)
N. Daffern, K. Kelley, … I. Radhakrishnan·bioRxiv·Jul 13, 2023
- Structural, Thermodynamic, and Dynamic Descriptors for Differential Mechanism of HIF-2 Activity Modulators
Rajat Punia, Gaurav Goel·Journal of Chemical Information and ModelingPeer-reviewed·Oct 10, 2025
- Structural insights into the cooperative interaction of the intrinsically disordered co-activator TIF2 with retinoic acid receptor heterodimer (RXR/RAR)
L. Senicourt, A. le Maire, … N. Sibille·bioRxiv·Oct 28, 2020
- Rational optimization of a transcription factor activation domain inhibitor
S. Basu, P. Martinez-Cristobal, … X. Salvatella·bioRxiv·Aug 18, 2022
- Capturing early events in aryl hydrocarbon receptor activation using two complementary protein-protein interaction assays
Tim Kuhn, Sarka Tumova, … Mirja Tamara Prentzell·bioRxiv·Jun 22, 2026
- High-throughput affinity measurements of direct interactions between activation domains and co-activators
Nicole V. DelRosso, Peter Suzuki, … Polly Morrell Fordyce·bioRxiv·Aug 19, 2024